AI filing briefs · archive

8-K filings in April 2024, explained

177 material Form 8-K filings that 165 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

12 of 177 briefs match

newest first · times in ET
SAIASAIA INC Apr 26, 4:09 PM ET

Saia CFO Douglas Col to retire; he stays until successor named, advisor through year-end

Neutral leadership Written later 5.02

Saia's Executive Vice President and Chief Financial Officer, Douglas Col, plans to retire after 10 years with the company, including the last four as CFO. He will remain in the role until a successor is named and will stay on as an advisor through year-end to support the transition. The change is a senior finance leadership transition, though the filing contains no financial results or new guidance.

  • Douglas Col informed Saia of his retirement plans on April 23, 2024, after 10 years of service
  • Col will continue as CFO until the company names a successor and will serve as an advisor through year-end
  • Company announced the retirement in a press release dated April 26, 2024 (Exhibit 99.1)
Read the filing on SEC.gov ↗
GGGGRACO INC Apr 26, 3:59 PM ET

Graco directors Mitau and Van Sant retire; shareholders approve 2019 plan amendment

Neutral leadership Written later 5.025.07

Graco directors Lee R. Mitau and R. William Van Sant left the Board on April 26, 2024, the day of the Annual Meeting. At the same meeting, shareholders approved the Amended and Restated 2019 Stock Incentive Plan, which adds 5,000,000 shares and extends the plan to April 26, 2034, and they elected three directors and ratified Deloitte & Touche LLP as auditor for fiscal 2024.

  • Lee R. Mitau retired under the Company's age-75 guideline; he reached 75 in October 2023.
  • R. William Van Sant's term expired at the Annual Meeting and he did not stand for re-election.
  • The Amended 2019 Plan adds 5,000,000 shares and extends its term to April 26, 2034; it received 129,931,724 votes for and 10,297,931 against.
  • Deloitte & Touche LLP was ratified for fiscal 2024 with 140,113,716 votes for and 9,660,446 against.
Read the filing on SEC.gov ↗
TMPTOMPKINS FINANCIAL CORP Apr 26, 9:13 AM ET

Tompkins Financial Q1 diluted EPS falls 12.6% to $1.18; net income down 13.0% from a year ago

Negative earnings Written later 2.028.01

Tompkins Financial reported first-quarter 2024 diluted earnings per share of $1.18 and net income of $16.9 million, down 12.6% and 13.0% from the first quarter of 2023, though up from the prior quarter. The decline was mainly due to lower net interest income from higher funding costs and a higher provision for credit losses, partly offset by fee growth and lower operating expenses. The Board also declared a $0.61 per share dividend payable May 17, 2024.

  • Diluted EPS was $1.18 versus $1.35 a year earlier and $1.05 in the fourth quarter of 2023.
  • Net interest income fell to $50.7 million from $54.2 million a year earlier; net interest margin was 2.73% versus 2.99%.
  • Noninterest income rose 8.5% year over year to $22.1 million, led by insurance commissions and fees.
  • Dividend of $0.61 per share: record date May 10, 2024; payable May 17, 2024.
Read the filing on SEC.gov ↗

Portland General Electric Q1 net income rises to $109 million; reaffirms 2024 guidance

Positive earnings Written later 2.027.01

Portland General Electric reported first-quarter 2024 GAAP net income of $109 million, or $1.08 per diluted share, up from $74 million, or $0.80 per diluted share, a year earlier. Total revenues rose to $929 million from $748 million, and the company reaffirmed its 2024 adjusted earnings guidance of $2.98 to $3.18 per diluted share, which matters to shareholders because it signals no change to the outlook.

  • GAAP net income of $109 million, or $1.08 per diluted share, for Q1 2024, versus $74 million, or $0.80 per diluted share, in Q1 2023
  • Total revenues of $929 million, versus $748 million in Q1 2023; purchased power and fuel expense rose to $405 million from $304 million
  • 2024 adjusted earnings guidance of $2.98 to $3.18 per diluted share reaffirmed, excluding January 2024 winter storm impacts
  • Quarterly common dividend of $0.50 per share, payable on or before July 15, 2024, to holders of record on June 24, 2024
Read the filing on SEC.gov ↗
SAIASAIA INC Apr 26, 8:32 AM ET

Saia Q1 revenue rises 14.3% to $754.8 million; diluted EPS $3.38 vs $2.85

Positive earnings Written later 2.02

Saia reported first quarter 2024 results with revenue up 14.3% to $754.8 million, operating income up 18.9% to $117.9 million, and diluted earnings per share of $3.38 versus $2.85 a year earlier. Management said winter weather hurt volumes and late-quarter shipments were below its expectations, and it expects net capital expenditures of about $1 billion in 2024, which shareholders should weigh against the company's rising debt and lower cash balance.

  • Revenue was $754.8 million, up 14.3%; operating income was $117.9 million, up 18.9%
  • Operating ratio improved to 84.4% from 85.0%; LTL shipments per workday rose 15.7%
  • Net capital expenditures were $456.8 million in the first quarter, and 2024 net capital expenditures are expected to be about $1 billion
  • Cash on hand was $12.3 million and total debt was $84.1 million at March 31, 2024, versus $166.4 million and $26.5 million a year earlier
Read the filing on SEC.gov ↗
BIOBIO-RAD LABORATORIES, INC. Apr 26, 8:30 AM ET

Bio-Rad says Life Science Group head Simon May resigns; James Barry to succeed

Neutral leadership Written later 5.025.077.01

Bio-Rad Laboratories said Simon May, Executive Vice President and President of the Life Science Group and a named executive officer, will resign effective May 1, 2024, to pursue another opportunity. James J. Barry, the company's Senior Vice President of Global Manufacturing, will take over that role on the same date. The filing also reports annual meeting votes, including stockholder approval of an amended 2017 Incentive Award Plan, but contains no financial results.

  • Simon May resigns as EVP and President, Life Science Group, effective May 1, 2024
  • James J. Barry appointed EVP and President, Life Science Group, effective May 1, 2024 (appointed April 24, 2024)
  • Stockholders approved the amended 2017 Incentive Award Plan at the April 23, 2024 annual meeting; plan expiration extended to February 9, 2034
Read the filing on SEC.gov ↗
PIPRPIPER SANDLER COMPANIES Apr 26, 8:04 AM ET

Piper Sandler Q1 net revenues rise 15% to $343 million; diluted EPS $2.43

Positive earnings Written later 2.02

Piper Sandler reported first-quarter 2024 net revenues of $343 million, up 15% from a year earlier but down 27% from the fourth quarter of 2023. Net income attributable to the company was $42.5 million, or $2.43 per diluted share, up 66% from the prior-year quarter. The board also declared a quarterly dividend of $0.60 per share, payable June 7, 2024.

  • Net revenues of $343 million, up 15% year over year and down 27% from the fourth quarter of 2023, driven by corporate investment banking
  • Net income attributable to Piper Sandler of $42.5 million, or $2.43 per diluted share, versus $1.49 a year earlier; adjusted diluted EPS was $2.79
  • Pre-tax margin of 15.3%, compared with 8.7% in the first quarter of 2023 and 18.2% in the fourth quarter of 2023
  • Quarterly dividend of $0.60 per share declared April 26, 2024, payable June 7, 2024 to holders of record on May 24, 2024
Read the filing on SEC.gov ↗
FHBFIRST HAWAIIAN, INC. Apr 26, 8:03 AM ET

First Hawaiian Q1 net income $54.2 million, $0.42 a share, up from prior quarter

Mixed earnings Written later 2.02

First Hawaiian reported first-quarter 2024 net income of $54.2 million, or $0.42 per diluted share, up from $47.5 million, or $0.37 per share, in the fourth quarter of 2023 but down from $66.8 million, or $0.52 per share, a year earlier. The company also declared a quarterly dividend of $0.26 per share, payable May 31, 2024, and reported total deposits down $663.2 million from the prior quarter.

  • Net income $54.2 million, $0.42 per diluted share, versus $0.37 in Q4 2023 and $0.52 in Q1 2023
  • Net interest margin rose 10 basis points to 2.91%; net interest income $154.4 million, up 1.7% from prior quarter
  • Total deposits fell $663.2 million to $20.7 billion; noninterest expense $128.8 million, down $13.5 million
  • Board declared $0.26 per share dividend on April 24, 2024; payable May 31 to holders of record May 20; no shares repurchased in Q1
Read the filing on SEC.gov ↗
CLCOLGATE PALMOLIVE CO Apr 26, 8:00 AM ET

Colgate-Palmolive Q1 EPS rises 84% to $0.83; raises full-year sales guidance

Positive guidance Written later 2.02

Colgate-Palmolive reported first-quarter 2024 net sales of $5,065 million, up 6.2%, and GAAP diluted EPS of $0.83, up 84% from $0.45. The company raised its full-year 2024 net sales and organic sales growth guidance, which supports the outlook for shareholders.

  • Net sales rose 6.2% to $5,065 million; organic sales rose 9.8%.
  • GAAP diluted EPS was $0.83 versus $0.45; Base Business EPS (non-GAAP) was $0.86 versus $0.73.
  • Full-year 2024 net sales growth guidance raised to 2% to 5% from 1% to 4%; organic sales growth guidance raised to 5% to 7% from 3% to 5%.
  • Net cash provided by operations was $681 million for the first three months of 2024.
Read the filing on SEC.gov ↗
GNTXGENTEX CORP Apr 26, 8:00 AM ET

Gentex Q1 2024 net sales hit record $590.2 million; EPS rose 12% to $0.47

Positive earnings Written later 2.02

Gentex reported first quarter 2024 results with record net sales of $590.2 million, up 7% from a year earlier, and diluted earnings per share of $0.47, up 12%. The company left its 2024 annual guidance unchanged, which keeps the revenue target at $2.45 to $2.55 billion for shareholders to track.

  • Net sales of $590.2 million, up 7% from $550.8 million in Q1 2023, a quarterly record
  • Net income of $108.2 million, up 11%; diluted EPS of $0.47 versus $0.42
  • Gross margin of 34.3%, up 260 basis points from 31.7%, but down slightly from the fourth quarter of 2023
  • 2024 annual guidance unchanged: revenue $2.45 to $2.55 billion, gross margin 34% to 35%
Read the filing on SEC.gov ↗
TROWPRICE T ROWE GROUP INC Apr 26, 7:22 AM ET

T. Rowe Price Q1 net income rose 36% to $573.8 million; diluted EPS $2.49

Positive earnings Written later 2.027.01

T. Rowe Price reported first-quarter 2024 results, with net revenues of $1.75 billion, up 13.8% from a year earlier, and net income attributable to the firm of $573.8 million, up 36.1%. Higher average assets under management and performance-based fees drove the gains, although the effective fee rate declined, and the firm also raised its quarterly dividend, which matters to shareholders because it signals continued payouts.

  • Net revenues of $1.75 billion in Q1 2024, up 13.8% from $1.54 billion in Q1 2023.
  • Diluted EPS of $2.49 versus $1.83 a year earlier; adjusted diluted EPS of $2.38 versus $1.69.
  • Net client outflows of $8.0 billion in Q1 2024; assets under management reached $1.54 trillion at March 31, 2024.
  • Quarterly dividend increased to $1.24 per share from $1.22, the 38th consecutive year of increases.
Read the filing on SEC.gov ↗
ROPROPER TECHNOLOGIES INC Apr 26, 7:01 AM ET

Roper Technologies raises 2024 outlook as first-quarter adjusted DEPS rises 13%

Positive guidance Written later 2.02

Roper reported first-quarter 2024 revenue of $1.68 billion, up 14%, with organic revenue up 8%. Adjusted DEPS rose 13% to $4.41 and GAAP DEPS rose 33% to $3.54. The company raised its full-year 2024 adjusted DEPS guidance to $18.05 to $18.25, from $17.85 to $18.15, and excludes unannounced future acquisitions.

  • Q1 2024 revenue $1.68 billion, up 14%; organic revenue up 8%, acquisitions added 6 points
  • Q1 2024 adjusted DEPS $4.41, up 13%; GAAP DEPS $3.54, up 33%
  • FY 2024 adjusted DEPS guidance raised to $18.05 to $18.25; Q2 2024 guidance $4.42 to $4.46
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.